Page last updated: 2024-10-29
iomeprol and Hilar Cholangiocarcinoma
iomeprol has been researched along with Hilar Cholangiocarcinoma in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Research Excerpts
Excerpt | Relevance | Reference |
"Cholangitis is the main complication post-endoscopic retrograde cholangiopancreatography (ERCP) in Klatskin patients, specially when medium contrast is injected into biliary tree that could not be subsequently drained." | 1.35 | Cholangitis prevention in endoscopic Klatskin tumor palliation: air cholangiography technique. ( Geraci, G; Modica, G; Pisello, F; Sciumè, C, 2009) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
Pisello, F | 1 |
Geraci, G | 1 |
Modica, G | 1 |
Sciumè, C | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status |
CO2 Cholangiography as an Alternative to Iodinated Contrast in Endoscopic Retrograde Cholangiopancreatography[NCT02611453] | | 40 participants (Anticipated) | Interventional | 2016-02-29 | Active, not recruiting |
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for iomeprol and Hilar Cholangiocarcinoma